Physician-prescribed weight management at Live Vital

Live Vital prescribes compounded medications, which a licensed pharmacy prepares for an individual patient. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. Research described below concerns the FDA-approved products that contain the same active ingredient. Prescription treatments require an evaluation by a licensed clinician; not all patients qualify. Outcomes vary by individual and are not guaranteed.

If you've been eating less, moving more, and still watching the scale refuse to budge — you're not failing. Your biology may be working against you. Weight regulation is governed by hormones and signaling peptides your body produces naturally, and when those systems are disrupted, willpower alone rarely fixes them.

Peptide therapy works differently from a calorie-restriction plan or a stimulant-based diet pill. It works with your body's own metabolic machinery — restoring the hormonal signals that control hunger, fat storage, and energy use. When those signals are recalibrated, sustainable weight loss becomes physiologically possible in a way that dieting simply cannot achieve.

This page is for people who have done the research, tried the conventional approaches, and want to understand whether physician-prescribed peptide therapy is the right next step.

Is Peptide Therapy Right for You?

Peptide therapy for weight loss is not a one-size-fits-all solution, and it is not appropriate for everyone. It tends to be the right fit when one or more of the following apply to you:

• You have a BMI over 27 with at least one weight-related health concern (elevated blood sugar, high blood pressure, high cholesterol, sleep apnea, or joint pain), or a BMI over 30
• You have tried structured diet and exercise programs without achieving or maintaining meaningful results
• You suspect — or have been told — that you have insulin resistance, metabolic syndrome, or prediabetes
• You are not currently pregnant, breastfeeding, or living with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome (which are contraindications to GLP-1 receptor agonists)
• You are looking for a medically supervised, evidence-based approach rather than an over-the-counter supplement

If you recognize yourself in that list, you are likely a candidate worth evaluating. The only way to know for certain is a direct conversation with a physician who can review your history, labs, and goals — which is exactly what the free consult with Dr. Taylor is designed for.

How Peptide Therapy Works for Weight Loss

To understand why these peptides work, you need to understand why weight loss is so hard in the first place.

Your body has a built-in defense system against weight loss. When you reduce calories, your brain interprets that as a threat and responds by increasing hunger hormones, lowering your resting metabolic rate, and reducing the satiety signals that tell you when to stop eating. This is why virtually every long-term diet study shows the same pattern: initial loss followed by plateau, then regain.

Peptide therapy interrupts that cycle at the hormonal level.

GLP-1 Receptor Agonists: Semaglutide and Tirzepatide

GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally releases after eating. It signals your pancreas to release insulin, tells your liver to stop releasing glucose, slows gastric emptying so you feel full longer, and — critically — acts directly on the hunger centers of the brain to reduce appetite.

In people with obesity or metabolic dysfunction, GLP-1 signaling is often blunted. GLP-1 receptor agonists like semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound) restore and amplify those signals.

Tirzepatide goes a step further by also activating GIP (glucose-dependent insulinotropic polypeptide) receptors, making it a dual agonist. This dual mechanism appears to produce stronger appetite suppression and greater average weight loss than GLP-1 agonists alone.

The Evidence

The clinical data behind these peptides is among the strongest ever published in obesity medicine.

Semaglutide — STEP 1 Trial (New England Journal of Medicine, 2021): In a 68-week randomized controlled trial of 1,961 adults with obesity, participants receiving weekly subcutaneous semaglutide (2.4 mg) lost an average of 14.9% of body weight, compared to 2.4% in the placebo group. Nearly 70% of participants lost more than 10% of their body weight, and one-third lost more than 20%. All participants received lifestyle intervention counseling alongside medication.

Tirzepatide — SURMOUNT-1 Trial (New England Journal of Medicine, 2022): In a 72-week trial of 2,539 adults with obesity or overweight with weight-related comorbidities, participants on the highest dose of tirzepatide (15 mg weekly) lost an average of 20.9% of body weight — with more than half losing at least 20% and nearly one in five losing 25% or more. This is a level of weight reduction that historically required bariatric surgery to achieve.

What a Treatment Protocol Looks Like

One of the most common reasons people hesitate to explore peptide therapy is fear of the unknown — needles, complicated schedules, side effects with no guidance. Here is exactly what to expect when you work with Dr. Taylor.

Step 1: Free Consultation (15 Minutes)

You meet with Dr. Taylor via telehealth. He reviews your health history, current medications, previous weight loss attempts, and goals. If you are a candidate, he will outline the specific protocol he recommends and explain why. If you are not a candidate, he will tell you that clearly and direct you appropriately.

Step 2: Lab Review (if needed)

Depending on your history, Dr. Taylor may request baseline labs — typically a metabolic panel, HbA1c, thyroid function, and lipid panel. Many patients already have recent labs they can share.

Step 3: Prescription and Dispensing

Peptides are prescribed and sent through a licensed compounding pharmacy that ships directly to your door. Medication arrives with clear dosing instructions.

Step 4: Dose Titration

GLP-1 agents are always started at a low dose and increased gradually over several weeks. This is the single most important factor in minimizing GI side effects. Dr. Taylor uses conservative titration schedules to ensure your body adapts comfortably before the dose increases.

Typical starting protocol (semaglutide example): - Weeks 1–4: 0.25 mg weekly injection - Weeks 5–8: 0.5 mg weekly - Weeks 9–12: 1.0 mg weekly - Ongoing: titrated to effect and tolerance, up to 2.4 mg if indicated

Step 5: Ongoing Check-Ins

You are not handed a prescription and left alone. Dr. Taylor conducts regular follow-up visits to track progress, manage any side effects, adjust dosing, and ensure the protocol is working as intended.

Patient Questions

1. Is it safe to use compounded semaglutide or tirzepatide instead of the brand-name drugs?

Compounded GLP-1 peptides sourced from FDA-registered 503B compounding pharmacies use the same active pharmaceutical ingredients as brand-name medications. The compounding process is regulated, and Dr. Taylor only works with pharmacies that meet those standards. The primary difference is cost and customization, not safety. That said, quality varies widely across the compounding industry — which is exactly why physician oversight matters.

2. Will I regain the weight when I stop?

This is the honest answer: without a maintenance strategy, some weight regain is possible — as it is with any intervention. GLP-1 signaling is partly restored during treatment, but the underlying metabolic predisposition does not disappear when the medication is stopped. Dr. Taylor builds a maintenance plan into every protocol, which may include a lower maintenance dose, a structured cycling approach, or a transition to other metabolic support. Patients who make lasting lifestyle changes during treatment tend to maintain the most.

3. I've heard GLP-1 drugs cause muscle loss. Is that true?

4. How long will it take to see results?

Most patients notice appetite changes within the first one to two weeks. Measurable weight loss typically becomes evident by weeks three to six as the dose titrates upward. Clinically significant results — 10% or more of body weight — are generally achieved between months three and six depending on starting dose and individual response. The SURMOUNT-1 trial (tirzepatide) achieved its headline results at 72 weeks. This is not a 30-day fix. It is a medically supervised process.

5. Do I need to be local to work with Dr. Taylor?

No. Dr. Taylor practices entirely via telehealth. Consultations, follow-ups, and prescription management are all conducted remotely. Medication ships directly to your home. The only thing that may require a local provider is lab work, which most patients can access through their existing primary care physician, a local lab, or an online lab-ordering service.

Related Reading